{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T03:07:38Z","timestamp":1793848058829,"version":"4.6.1"},"reference-count":63,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.clinthera.2026.04.008","type":"journal-article","created":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T21:21:06Z","timestamp":1778880066000},"page":"623-647","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Implications of TLR4 Polymorphisms for Precision Therapeutics in Gram-negative Infections: An Ethnogeographic-Stratified Meta-Analysis"],"prefix":"10.1016","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8015-3223","authenticated-orcid":false,"given":"Beatriz Giraldo","family":"Ospina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0741-4762","authenticated-orcid":false,"given":"Iv\u00e1n Alberto Lopera","family":"Castrill\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9547-967X","authenticated-orcid":false,"given":"Sandra Catalina Garz\u00f3n","family":"Casta\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-0087-6854","authenticated-orcid":false,"given":"Daniel Duque","family":"Tob\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6156-1619","authenticated-orcid":false,"given":"Diego Fernando L\u00f3pez","family":"Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2026.04.008_bib0001","article-title":"Combating Gram-negative infections: the role of antimicrobial peptides and nanotechnology in overcoming antibiotic resistance","volume":"35","author":"Carnero Canales","year":"2025","journal-title":"Mater Today Bio"},{"key":"10.1016\/j.clinthera.2026.04.008_bib0002","doi-asserted-by":"crossref","first-page":"5419","DOI":"10.2147\/IDR.S530557","article-title":"Antimicrobial resistance: a rising global threat to public health","volume":"18","author":"Patra","year":"2025","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.clinthera.2026.04.008_bib0003","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijregi.2023.01.002","article-title":"Epidemiology and mortality outcome of carbapenem- and colistin-resistant Klebsiella pneumoniae, Escherichia coli, Acinetobacter baumannii, and Pseudomonas aeruginosa bloodstream infections","volume":"7","author":"Balkhair","year":"2023","journal-title":"IJID Regions"},{"key":"10.1016\/j.clinthera.2026.04.008_bib0004","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s12941-025-00811-w","article-title":"Bacteriological profile and antimicrobial resistance in sepsis cases in intensive care units in Lubumbashi: challenges and perspectives","volume":"24","author":"Manika","year":"2025","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"10.1016\/j.clinthera.2026.04.008_bib0005","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1186\/s12879-024-09256-6","article-title":"Carbapenem-resistant gram-negative bacterial infections and risk factors for acquisition in a Kenyan intensive care unit","volume":"24","author":"Maina","year":"2024","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.clinthera.2026.04.008_bib0006","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222413397","article-title":"Toll-Like Receptors (TLRs), NOD-Like Receptors (NLRs), and RIG-I-Like Receptors (RLRs) in Innate Immunity. TLRs, NLRs, and RLRs Ligands as Immunotherapeutic Agents for Hematopoietic Diseases","volume":"22","author":"Wicherska-Paw\u0142owska","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.clinthera.2026.04.008_bib0007","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.3892\/etm.2014.2025","article-title":"Toll-like receptor 4 agonist, lipopolysaccharide, increases the expression levels of cytokines and chemokines in human peripheral blood mononuclear cells","volume":"8","author":"Pu","year":"2014","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.clinthera.2026.04.008_bib0008","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.745325","article-title":"Activation of toll-like receptors by live gram-negative bacterial pathogens reveals mitigation of TLR4 responses and activation of TLR5 by flagella","volume":"11","author":"Amemiya","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.clinthera.2026.04.008_bib0009","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1007\/s00018-020-03656-y","article-title":"TLR4 and CD14 trafficking and its influence on LPS-induced pro-inflammatory signaling","volume":"78","author":"Ciesielska","year":"2021","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.clinthera.2026.04.008_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110755","article-title":"A TLR4-independent critical role for CD14 in intracellular LPS sensing","volume":"39","author":"Vasudevan","year":"2022","journal-title":"Cell Rep"},{"key":"10.1016\/j.clinthera.2026.04.008_bib0011","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000031247","article-title":"An updated systematic review of the association between the TLR4 polymorphism rs4986790 and cancers risk","volume":"101","author":"Xiao","year":"2022","journal-title":"Medicine"},{"key":"10.1016\/j.clinthera.2026.04.008_bib0012","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.immuni.2024.03.004","article-title":"Decoding Toll-like receptors: recent insights and perspectives in innate immunity","volume":"57","author":"Kawai","year":"2024","journal-title":"Immunity"},{"key":"10.1016\/j.clinthera.2026.04.008_bib0013","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.3390\/cells11193137","article-title":"The toll-like receptor 4 polymorphism Asp299Gly is associated with an increased risk of ovarian cancer","volume":"11","author":"Kania","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.clinthera.2026.04.008_bib0014","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2019\/6503832","article-title":"The role of TLR4 Asp299Gly and TLR4 Thr399Ile polymorphisms in the pathogenesis of urinary tract infections: first evaluation in infants and children of Greek origin","volume":"2019","author":"Karananou","year":"2019","journal-title":"J Immunol Res"},{"key":"10.1016\/j.clinthera.2026.04.008_bib0015","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1111\/apm.13463","article-title":"Association of TLR4 polymorphisms (Asp299Gly and Thr399Ile) with sepsis: a meta-analysis and trial sequence analysis","volume":"132","author":"Mu","year":"2024","journal-title":"APMIS"},{"key":"10.1016\/j.clinthera.2026.04.008_bib0016","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s12979-023-00383-3","article-title":"Toll-like receptor 4 (TLR4): new insight immune and aging","volume":"20","author":"Kim","year":"2023","journal-title":"Immunity Ageing"},{"key":"10.1016\/j.clinthera.2026.04.008_bib0017","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"15","key":"10.1016\/j.clinthera.2026.04.008_bib0018","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: a proposal for reporting","volume":"283","author":"Stroup","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.clinthera.2026.04.008_bib0019","unstructured":"Giraldo Ospina B., Lopera Castrillon I.A., Garz\u00f3n Casta\u00f1o S.C., L\u00f3pez Mu\u00f1oz D.F. Implications of TLR4 polymorphisms for precision therapeutics in Gram-negative infections: an ethnogeographic-stratified meta-analysis. 2025. PROSPERO 2025 CRD420251155764. Available from https:\/\/www.crd.york.ac.uk\/PROSPERO\/view\/CRD420251155764"},{"key":"10.1016\/j.clinthera.2026.04.008_bib0020","doi-asserted-by":"crossref","DOI":"10.1136\/emermed-2020-209567","article-title":"Population, Intervention, Comparison, Outcomes and Study (PICOS) design as a framework to formulate eligibility criteria in systematic reviews","volume":"37","author":"Amir-Behghadami","year":"2020","journal-title":"Emerg Med J"},{"key":"10.1016\/j.clinthera.2026.04.008_bib0021","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2013.00003","article-title":"Recognition of lipid A variants by the TLR4-MD-2 receptor complex","volume":"3","author":"Maeshima","year":"2013","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.clinthera.2026.04.008_bib0022","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1471-2288-14-45","article-title":"Newcastle-Ottawa Scale: comparing reviewers\u2019 to authors\u2019 assessments","volume":"14","author":"Lo","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.clinthera.2026.04.008_bib0023","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jclinepi.2015.11.017","article-title":"A guide for health professionals to interpret and use recommendations in guidelines developed with the GRADE approach","volume":"72","author":"Neumann","year":"2016","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.clinthera.2026.04.008_bib0024","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/jrsm.1411","article-title":"Risk-of-bias VISualization (robvis): an R package and Shiny web app for visualizing risk-of-bias assessments","volume":"12","author":"McGuinness","year":"2021","journal-title":"Res Synth Methods"},{"key":"10.1016\/j.clinthera.2026.04.008_bib0025","series-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Collaboration","year":"2019"},{"key":"10.1016\/j.clinthera.2026.04.008_bib0026","article-title":"PRISMA 2020 : an R package and Shiny app for producing PRISMA 2020-compliant flow diagrams, with interactivity for optimised digital transparency and Open Synthesis","volume":"18","author":"Haddaway","year":"2022","journal-title":"Campbell Syst Rev"},{"key":"10.1016\/j.clinthera.2026.04.008_bib0027","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.22207\/JPAM.16.4.67","article-title":"Frequency of meningococcal meningitis susceptibility associated TLR4 +896 A\/G (rs4986790) allele in the Saudi Population","volume":"16","author":"Alisaac","year":"2022","journal-title":"J Pure Appl Microbiol"},{"key":"10.1016\/j.clinthera.2026.04.008_bib0028","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.5958\/0973-9130.2019.00454.7","article-title":"Influence of TLR4 polymorphisms on susceptibility to UTI caused by gram negative bacteria in pregnant women","volume":"13","author":"MAK","year":"2019","journal-title":"Indian J Forensic Med Toxicol"},{"key":"10.1016\/j.clinthera.2026.04.008_bib0029","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.31557\/APJCP.2020.21.11.3177","article-title":"Clinical implication of toll-like receptors (TLR2 and TLR4) in acute myeloid leukemia patients","volume":"21","author":"Aref","year":"2020","journal-title":"Asian Pacific J Cancer Prevent"},{"key":"10.1016\/j.clinthera.2026.04.008_bib0030","doi-asserted-by":"crossref","first-page":"94","DOI":"10.4103\/ijmm.IJMM_20_164","article-title":"Association of toll-like receptors 2, 4, 9 and 10 genes polymorphisms and helicobacter pylori-related gastric diseases in Saudi patients","volume":"38","author":"Eed","year":"2020","journal-title":"Indian J Med Microbiol"},{"key":"10.1016\/j.clinthera.2026.04.008_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.exppara.2024.108857","article-title":"The molecular and histopathological investigations of TLR2 rs5743708 and TLR4 (rs4986790 and rs4986791) polymorphisms effects on cutaneous leishmaniasis lesions","volume":"267","author":"Feiz-Haddad","year":"2024","journal-title":"Exp Parasitol"},{"key":"10.1016\/j.clinthera.2026.04.008_bib0032","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1055\/s-0040-1714710","article-title":"Role of toll-like receptors 2 and 4 genes polymorphisms in neonatal sepsis in a developing country: a pilot study","volume":"15","author":"Khaled","year":"2020","journal-title":"J Pediatr Infect Dis"},{"key":"10.1016\/j.clinthera.2026.04.008_bib0033","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231810982","article-title":"Investigation of TLR2 and TLR4 Polymorphisms and Sepsis Susceptibility: computational and Experimental Approaches","volume":"23","author":"Behairy","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.clinthera.2026.04.008_bib0034","first-page":"165","article-title":"The role of toll-like receptor 4 gene polymorphism TLR4 (Thr399Ile) and expression in adult urinary tract infections pathogenesis","volume":"23","author":"Hekmat","year":"2024","journal-title":"Iraqi J Biotechnol"},{"key":"10.1016\/j.clinthera.2026.04.008_bib0035","doi-asserted-by":"crossref","first-page":"9430","DOI":"10.3390\/ijms23169430","article-title":"Single nucleotide polymorphisms of toll-like receptor 4 in hepatocellular carcinoma\u2014a single-center study","volume":"23","author":"Androutsakos","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.clinthera.2026.04.008_bib0036","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jcrc.2018.05.012","article-title":"Toll-like receptor 2, 4 and 9 polymorphisms and their association with ICU-acquired infections in Central Greece","volume":"47","author":"Chatzi","year":"2018","journal-title":"J Crit Care"},{"key":"10.1016\/j.clinthera.2026.04.008_bib0037","doi-asserted-by":"crossref","first-page":"702","DOI":"10.4049\/jimmunol.2300518","article-title":"A Lipopolysaccharide-Enriched Cow\u2019s Milk Allergy Microbiome Promotes a TLR4-Dependent Proinflammatory Intestinal Immune Response","volume":"212","author":"Campbell","year":"2024","journal-title":"The Journal of Immunology"},{"key":"10.1016\/j.clinthera.2026.04.008_bib0038","doi-asserted-by":"crossref","first-page":"57","DOI":"10.17219\/acem\/152885","article-title":"Toll-like receptor polymorphisms (TLR2 and TLR4) association with the risk of infectious complications in cardiac surgery patients","volume":"32","author":"Zukowska","year":"2022","journal-title":"Adv Clin Exp Med"},{"key":"10.1016\/j.clinthera.2026.04.008_bib0039","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/iji.12676","article-title":"Genetic polymorphisms of TLR1, TLR2,TLR3 and TLR4 in patients with recurrent or severe infections","volume":"51","author":"Ter\u00e4sj\u00e4rvi","year":"2024","journal-title":"Int J Immunogenet"},{"key":"10.1016\/j.clinthera.2026.04.008_bib0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2019.152692","article-title":"The relationship between TLR4 rs4986790 and rs4986791 gene polymorphisms and Helicobacter pylori infection in children with gastritis","volume":"215","author":"Meli\u0163","year":"2019","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.clinthera.2026.04.008_bib0041","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1016\/j.jtho.2019.07.023","article-title":"Gram-negative pneumonia augments non\u2013small cell lung cancer metastasis through host toll-like receptor 4 activation","volume":"14","author":"Gowing","year":"2019","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.clinthera.2026.04.008_bib0042","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.745325","article-title":"Activation of toll-like receptors by live gram-negative bacterial pathogens reveals mitigation of TLR4 responses and activation of TLR5 by flagella","volume":"11","author":"Amemiya","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.clinthera.2026.04.008_bib0043","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.111612","article-title":"Effect of lipopolysaccharide on TAK1-mediated hepatocyte PANoptosis through Toll-like receptor 4 during acute liver failure","volume":"129","author":"Li","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.clinthera.2026.04.008_bib0044","doi-asserted-by":"crossref","first-page":"31","DOI":"10.4103\/jmedsci.jmedsci_110_23","article-title":"Polymorphism of toll-like receptor 4 is correlated with an increased risk of mortality of hemodialysis patients: a retrospective cohort study in Taiwanese","volume":"44","author":"Lee","year":"2024","journal-title":"J Med Sci"},{"key":"10.1016\/j.clinthera.2026.04.008_bib0045","article-title":"Exploring the role of cathelicidin antimicrobial peptide, toll-like receptor 4, and HMGB-1 in bacterial infection","volume":"22","author":"Febriza","year":"2024","journal-title":"Antiinfect Agents"},{"key":"10.1016\/j.clinthera.2026.04.008_bib0046","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1007\/s10388-025-01140-9","article-title":"Porphyromonas gingivalis levels correlate with TLR4 expression status and prognosis after esophagectomy for advanced thoracic esophageal squamous cell carcinoma","volume":"22","author":"Yoneya","year":"2025","journal-title":"Esophagus"},{"key":"10.1016\/j.clinthera.2026.04.008_bib0047","doi-asserted-by":"crossref","DOI":"10.1038\/srep17997","article-title":"Energetics of endotoxin recognition in the toll-like receptor 4 innate immune response","volume":"5","author":"Paramo","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.clinthera.2026.04.008_bib0048","doi-asserted-by":"crossref","DOI":"10.1016\/j.exppara.2022.108243","article-title":"Polymorphisms of the TLR4 gene: risk factor for chronicity and severity in oral vectorial Chagas disease","volume":"238","author":"S\u00e1nchez","year":"2022","journal-title":"Exp Parasitol"},{"key":"10.1016\/j.clinthera.2026.04.008_bib0049","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s00467-023-06063-0","article-title":"Urine soluble TLR4 levels may contribute to predict urinary tract infection in children: the UTILISE Study","volume":"39","author":"Aksu","year":"2024","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.clinthera.2026.04.008_bib0050","doi-asserted-by":"crossref","first-page":"758","DOI":"10.24953\/turkjped.2023.389","article-title":"Evaluation of toll-like receptors 2 and 4 polymorphism and intestinal microbiota in children with food allergies","volume":"65","author":"K\u0131l\u0131\u00e7","year":"2023","journal-title":"Turk J Pediatr"},{"key":"10.1016\/j.clinthera.2026.04.008_bib0051","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1080\/08820139.2020.1716787","article-title":"Study of toll-like receptor 4 gene polymorphisms in colorectal cancer: correlation with clinicopathological features","volume":"49","author":"Moaaz","year":"2020","journal-title":"Immunol Invest"},{"key":"10.1016\/j.clinthera.2026.04.008_bib0052","doi-asserted-by":"crossref","first-page":"124","DOI":"10.4254\/wjh.v10.i1.124","article-title":"Toll-like receptor 4 polymorphisms and bacterial infections in patients with cirrhosis and ascites","volume":"10","author":"Alvarado-Tapias","year":"2018","journal-title":"World J Hepatol"},{"key":"10.1016\/j.clinthera.2026.04.008_bib0053","doi-asserted-by":"crossref","DOI":"10.5935\/0103-507X.20220010-en","article-title":"Prognostic value of hyperlactatemia in infected patients admitted to intensive care units: a multicenter study","volume":"34","author":"Silva","year":"2022","journal-title":"Rev Bras Ter Intensiva"},{"key":"10.1016\/j.clinthera.2026.04.008_bib0054","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000031247","article-title":"An updated systematic review of the association between the TLR4 polymorphism rs4986790 and cancers risk","volume":"101","author":"Xiao","year":"2022","journal-title":"Medicine"},{"key":"10.1016\/j.clinthera.2026.04.008_bib0055","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1021\/acs.jmedchem.2c01998","article-title":"New Glucosamine-based TLR4 agonists: design, synthesis, mechanism of action, and in vivo activity as vaccine adjuvants","volume":"66","author":"Romerio","year":"2023","journal-title":"J Med Chem"},{"key":"10.1016\/j.clinthera.2026.04.008_bib0056","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1007\/s00018-020-03656-y","article-title":"TLR4 and CD14 trafficking and its influence on LPS-induced pro-inflammatory signaling","volume":"78","author":"Ciesielska","year":"2021","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.clinthera.2026.04.008_bib0057","doi-asserted-by":"crossref","first-page":"1","DOI":"10.21926\/obm.genet.2502293","article-title":"The roles of IL-6, IL-8, and TNF-\u03b1 in pediatric immune defense and infection severity","volume":"09","author":"Obaji","year":"2025","journal-title":"OBM Genet"},{"key":"10.1016\/j.clinthera.2026.04.008_bib0058","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s12979-023-00383-3","article-title":"Toll-like receptor 4 (TLR4): new insight immune and aging","volume":"20","author":"Kim","year":"2023","journal-title":"Immunity Ageing"},{"key":"10.1016\/j.clinthera.2026.04.008_bib0059","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.585146","article-title":"Lipopolysaccharide recognition in the crossroads of TLR4 and caspase-4\/11 mediated inflammatory pathways","volume":"11","author":"Zamyatina","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.clinthera.2026.04.008_bib0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007684","article-title":"The TLR4 adaptor TRAM controls the phagocytosis of Gram-negative bacteria by interacting with the Rab11-family interacting protein 2","volume":"15","author":"Skjesol","year":"2019","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.clinthera.2026.04.008_bib0061","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1002\/med.21553","article-title":"Recent clinical trends in Toll-like receptor targeting therapeutics","volume":"39","author":"Anwar","year":"2019","journal-title":"Med Res Rev"},{"key":"10.1016\/j.clinthera.2026.04.008_bib0062","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.ebiom.2019.03.069","article-title":"Clinical and genetic landscape of treatment naive cervical cancer: alterations in PIK3CA and in epigenetic modulators associated with sub-optimal outcome","volume":"43","author":"Scholl","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.clinthera.2026.04.008_bib0063","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/s00018-025-05631-x","article-title":"Role of TLRs as signaling cascades to combat infectious diseases: a review","volume":"82","author":"Md","year":"2025","journal-title":"Cell Mol Life Sci"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291826001104?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291826001104?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T20:42:57Z","timestamp":1781210577000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291826001104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":63,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S0149291826001104"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2026.04.008","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Implications of TLR4 Polymorphisms for Precision Therapeutics in Gram-negative Infections: An Ethnogeographic-Stratified Meta-Analysis","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2026.04.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}